Medicine & Health Blogs

Lutetium-177 PSMA targeted therapy for prostate cancer in India 2026 — A.K. Pharma medicine distributor Delhi

Blog

Lutetium-177 PSMA Therapy for Prostate Cancer in India — Who Qualifies, How It Works, and Where to Access It in 2026

For most of the past two decades, Indian men diagnosed with advanced prostate cancer had a fairly narrow set of treatment options — hormone therapy, chemotherapy if the cancer progressed, and more recently oral targeted medicines like Enzalutamide (Glenza) and Abiraterone (Abirapro). These are genuinely effective medicines, but they work

May 7, 2026 No Comments

Cancer

Enhertu and the ADC Revolution — Why Antibody-Drug Conjugates Are the Most Important Development in Cancer Treatment in 2026

In December 2019 the FDA approved a new cancer medicine that most oncologists had never heard of. By 2024 it had become the best-selling antibody-drug conjugate in the world — generating USD 3.75 billion in annual sales. By early 2026 it had received Priority Review for yet another new indication

April 27, 2026 No Comments

GLP-1 Medicines in India 2026" on a light green gradient background. It features line drawings of three different medical injector pens positioned diagonally. Below the first pen on the left is the text "Ozempic", below the middle pen is "Mounjaro", and below the right pen is "Wegovy", all in dark green text.

Diabetes

Ozempic vs Mounjaro vs Wegovy in India 2026 — Which GLP-1 Should Your Patient Choose?

India’s diabetes and obesity treatment landscape changed dramatically in March 2026. Novo Nordisk’s core Indian patent for semaglutide expired on March 20, 2026 — within hours, a wave of Indian pharmaceutical companies launched their own versions at dramatically lower prices. Branded Ozempic costs ₹8,800–₹11,175 per month in India, while the

April 13, 2026 No Comments

Medicine Wholsaler

How A.K. Pharma Ensures Genuine Medicine Supply Across India

When hospitals, clinics, and pharmacies look for a medicine supplier, the most important factor is trust. Counterfeit or substandard medicines are a serious concern in India — and choosing the wrong supplier can put patients at risk. At A.K. Pharma, we understand this responsibility. As a licensed medicine wholesaler in

March 20, 2026 No Comments

Lutetium-177 PSMA Therapy for Prostate Cancer in India — Who Qualifies, How It Works, and Where to Access It in 2026

Enhertu and the ADC Revolution — Why Antibody-Drug Conjugates Are the Most Important Development in Cancer Treatment in 2026

Ozempic vs Mounjaro vs Wegovy in India 2026 — Which GLP-1 Should Your Patient Choose?

How A.K. Pharma Ensures Genuine Medicine Supply Across India

Menu

Quote Request Form

Quote Request Form